Trial intelligence / Profile preview

Dexmedetomidine during open nephrolithotomy for intraoperative hemodynamics and blood loss

ACTRN12614000389606Phase 2Completed

Sponsor
Beni-Suef University Hospital
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of dexmedetomidine in Lithiasis (2 arms), sponsored by Beni-Suef University Hospital. Primary endpoint: Heart rate. Started Apr 2014; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Lithiasis

Beyond the preview

Go deeper on ACTRN12614000389606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614000389606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call